The Service of the Commission for the Protection of Competition announces that it has received a notification of concentration by regarding the acquisition of the share capital of Corden Pharma Holding S.E. and Corden Pharma US Holdings, Inc.by Astrong Fund VIII, SCSp.
Astorg Fund VIII, SCSp. is a special limited liability partnership managed by Astorg Asset Management S.à.r.l (hereafter “AAM”) which is authorized as an Alternative Investment Fund Manager (AIFM) regulated by CSSF of Luxembourg. The AAM and all the affiliated companies and funds are owned by Astorg Fund VIII (hereafter the “Astorg Group”). Astorg Group is an independent private investment company that invests and acquires businesses.
Corden Pharma Holding S.E. is a company duly registered under the law Luxembourg and Corden Pharma US Holdings, Inc. is a company duly registered under the law of the State of Delaware of the United States of America (Both hereafter as the “Target”). The Target provides development and manufacturing services of pharmaceutical products to a third-party pharmaceutical company under a contract (Contract Development Manufacturing Organizations, “CDMO”).